|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gupta GP and Massagué J: Cancer
metastasis: building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
ten Kate M, Hofland LJ, van Grevenstein
WM, van Koetsveld PV, Jeekel J and van Eijck CH: Influence of
proinflammatory cytokines on the adhesion of human colon carcinoma
cells to lung microvascular endothelium. Int J Cancer. 112:943–950.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Basoglu M, Yildirgan MI, Taysi S, Yilmaz
I, Kiziltunc A, Balik AA, Celebi F and Atamanalp SS: Levels of
soluble inter-cellular adhesion molecule-1 and total sialic acid in
serum of patients with colorectal cancer. J Surg Oncol. 83:180–184.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fidler IJ: Critical determinants of
metastasis. Semin Cancer Biol. 12:89–96. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chan DA and Giaccia AJ: Hypoxia, gene
expression, and metastasis. Cancer Metastasis Rev. 26:333–339.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Toh Y and Nicolson GL: The role of the MTA
family and their encoded proteins in human cancers: molecular
functions and clinical implications. Clin Exp Metastasis.
26:215–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kumar R, Wang RA, Mazumdar A, Talukder AH,
Mandal M, Yang Z, Bagheri-Yarmand R, Sahin A, Hortobagyi G, Adam L,
et al: A naturally occurring MTA1 variant sequesters oestrogen
receptor-alpha in the cytoplasm. Nature. 418:654–657. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Toh Y, Pencil SD and Nicolson GL: A novel
candidate metastasis-associated gene, mta1, differentially
expressed in highly metastatic mammary adenocarcinoma cell lines.
cDNA cloning, expression, and protein analyses. J Biol Chem.
269:22958–22963. 1994.PubMed/NCBI
|
|
10
|
Li DQ, Pakala SB, Nair SS, Eswaran J and
Kumar R: Metastasis-associated protein 1/nucleosome remodeling and
histone deacetylase complex in cancer. Cancer Res. 72:387–394.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Okugawa Y, Toiyama Y, Hur K, Toden S,
Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR, et
al: Metastasis-associated long non-coding RNA drives gastric cancer
development and promotes peritoneal metastasis. Carcinogenesis.
35:2731–2739. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Okugawa Y, Tanaka K, Inoue Y, Kawamura M,
Kawamoto A, Hiro J, Saigusa S, Toiyama Y, Ohi M, Uchida K, et al:
Brain-derived neurotrophic factor/tropomyosin-related kinase B
pathway in gastric cancer. Br J Cancer. 108:121–130. 2013.
View Article : Google Scholar :
|
|
13
|
Okugawa Y, Inoue Y, Tanaka K, Kawamura M,
Saigusa S, Toiyama Y, Ohi M, Uchida K, Mohri Y and Kusunoki M: Smad
interacting protein 1 (SIP1) is associated with peritoneal
carcinomatosis in intestinal type gastric cancer. Clin Exp
Metastasis. 30:417–429. 2013. View Article : Google Scholar
|
|
14
|
Okugawa Y, Toiyama Y, Tanaka K, Matsusita
K, Fujikawa H, Saigusa S, Ohi M, Inoue Y, Mohri Y, Uchida K, et al:
Clinical significance of zinc finger E-box binding homeobox 1
(ZEB1) in human gastric cancer. J Surg Oncol. 106:280–285. 2012.
View Article : Google Scholar
|
|
15
|
Toiyama Y, Tanaka K, Kitajima T, Shimura
T, Imaoka H, Mori K, Okigami M, Yasuda H, Okugawa Y, Saigusa S, et
al: Serum angiopoietin-like protein 2 as a potential biomarker for
diagnosis, early recurrence and prognosis in gastric cancer
patients. Carcinogenesis. 36:1474–1483. 2015.PubMed/NCBI
|
|
16
|
Japanese Gastric Cancer Association:
Japanese Classification of Gastric Carcinoma (3rd English ed).
14:101–112. 2011.
|
|
17
|
Dias SJ, Zhou X, Ivanovic M, Gailey MP,
Dhar S, Zhang L, He Z, Penman AD, Vijayakumar S and Levenson AS:
Nuclear MTA1 overexpression is associated with aggressive prostate
cancer, recurrence and metastasis in African Americans. Sci Rep.
3:23312013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pakala SB, Rayala SK, Wang RA, Ohshiro K,
Mudvari P, Reddy SD, Zheng Y, Pires R, Casimiro S, Pillai MR, et
al: MTA1 promotes STAT3 transcription and pulmonary metastasis in
breast cancer. Cancer Res. 73:3761–3770. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li WF, Liu N, Cui RX, He QM, Chen M, Jiang
N, Sun Y, Zeng J, Liu LZ and Ma J: Nuclear overexpression of
metastasis-associated protein 1 correlates significantly with poor
survival in nasopharyngeal carcinoma. J Transl Med. 10:782012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang W, Yang ZL, Liu JQ, Yang LP, Yang XJ
and Fu X: Overexpression of MTA1 and loss of KAI-1 and KiSS-1
expressions are associated with invasion, metastasis, and
poor-prognosis of gallbladder adenocarcinoma. Tumori. 100:667–674.
2014.
|
|
21
|
Covington KR, Brusco L, Barone I,
Tsimelzon A, Selever J, Corona-Rodriguez A, Brown P, Kumar R,
Hilsenbeck SG and Fuqua SA: Metastasis tumor-associated protein 2
enhances metastatic behavior and is associated with poor outcomes
in estrogen receptor-negative breast cancer. Breast Cancer Res
Treat. 141:375–384. 2013. View Article : Google Scholar
|
|
22
|
Liu T, Yang M, Yang S, Ge T, Gu L and Lou
G: Metastasis-associated protein 1 is a novel marker predicting
survival and lymph nodes metastasis in cervical cancer. Hum Pathol.
44:2275–2281. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li H, Sun L, Xu Y, Li Z, Luo W, Tang Z,
Qiu X and Wang E: Overexpression of MTA3 correlates with tumor
progression in non-small cell lung cancer. PLoS One. 8:e666792013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Manavathi B and Kumar R: Metastasis tumor
antigens, an emerging family of multifaceted master coregulators. J
Biol Chem. 282:1529–1533. 2007. View Article : Google Scholar
|
|
25
|
Manavathi B, Singh K and Kumar R: MTA
family of coregulators in nuclear receptor biology and pathology.
Nucl Recept Signal. 5:e0102007.
|
|
26
|
Kumar R, Wang RA and Bagheri-Yarmand R:
Emerging roles of MTA family members in human cancers. Semin Oncol.
30(Suppl 16): 30–37. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qian H, Lu N, Xue L, Liang X, Zhang X, Fu
M, Xie Y, Zhan Q, Liu Z and Lin C: Reduced MTA1 expression by RNAi
inhibits in vitro invasion and migration of esophageal squamous
cell carcinoma cell line. Clin Exp Metastasis. 22:653–662. 2005.
View Article : Google Scholar
|
|
28
|
Sasaki H, Yukiue H, Kobayashi Y, Nakashima
Y, Kaji M, Fukai I, Kiriyama M, Yamakawa Y and Fujii Y: Expression
of the MTA1 mRNA in thymoma patients. Cancer Lett. 174:159–163.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dannenmann C, Shabani N, Friese K, Jeschke
U, Mylonas I and Brüning A: The metastasis-associated gene MTA1 is
upregulated in advanced ovarian cancer, represses ERbeta, and
enhances expression of oncogenic cytokine GRO. Cancer Biol Ther.
7:1460–1467. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tong D, Heinze G, Schremmer M, Schuster E,
Czerwenka K, Leodolter S and Zeillinger R: Expression of the human
MTA1 gene in breast cell lines and in breast cancer tissues. Oncol
Res. 16:465–470. 2007. View Article : Google Scholar
|
|
31
|
Tuncay Cagatay S, Cimen I, Savas B and
Banerjee S: MTA-1 expression is associated with metastasis and
epithelial to mesenchymal transition in colorectal cancer cells.
Tumour Biol. 34:1189–1204. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li J, Ye L, Sun PH, Satherley L, Hargest
R, Zhang Z and Jiang WG: MTA1 is up-regulated in colorectal cancer
and is inversely correlated with lymphatic metastasis. Cancer
Genomics Proteomics. 12:339–345. 2015.PubMed/NCBI
|
|
33
|
Avtanski DB, Nagalingam A, Kuppusamy P,
Bonner MY, Arbiser JL, Saxena NK and Sharma D: Honokiol abrogates
leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin
signaling axis in a microRNA-34a dependent manner. Oncotarget.
6:16396–16410. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fujita N, Jaye DL, Kajita M, Geigerman C,
Moreno CS and Wade PA: MTA3, a Mi-2/NuRD complex subunit, regulates
an invasive growth pathway in breast cancer. Cell. 113:207–219.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ji Y, Zhang P, Lu Y and Ma D: Expression
of MTA2 gene in ovarian epithelial cancer and its clinical
implication. J Huazhong Univ Sci Technolog Med Sci. 26:359–362.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen DW, Fan YF, Li J and Jiang XX: MTA2
expression is a novel prognostic marker for pancreatic ductal
adenocarcinoma. Tumour Biol. 34:1553–1557. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu SL, Han Y, Zhang Y, Xie CY, Wang EH,
Miao Y, Li HY, Xu HT and Dai SD: Expression of
metastasis-associated protein 2 (MTA2) might predict proliferation
in non-small cell lung cancer. Target Oncol. 7:135–143. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dong H, Guo H, Xie L, Wang G, Zhong X,
Khoury T, Tan D and Zhang H: The metastasis-associated gene MTA3, a
component of the Mi-2/NuRD transcriptional repression complex,
predicts prognosis of gastroesophageal junction adenocarcinoma.
PLoS One. 8:e629862013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou C, Ji J, Cai Q, Shi M, Chen X, Yu Y,
Liu B, Zhu Z and Zhang J: MTA2 promotes gastric cancer cells
invasion and is transcriptionally regulated by Sp1. Mol Cancer.
12:1022013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yao Y, Feng S, Xiao M, Li Y, Yang L and
Gong J: MTA1 promotes proliferation and invasion in human gastric
cancer cells. Onco Targets Ther. 8:1785–1794. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhou C, Ji J, Cai Q, Shi M, Chen X, Yu Y,
Zhu Z and Zhang J: MTA2 enhances colony formation and tumor growth
of gastric cancer cells through IL-11. BMC Cancer. 15:3432015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen
JH, Li AF, Lui WY and Whang-Peng J: Nodal dissection for patients
with gastric cancer: a randomised controlled trial. Lancet Oncol.
7:309–315. 2006. View Article : Google Scholar : PubMed/NCBI
|
